Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Mar. 31, 2018
Sales, net	$ 14,088	$ 10,575	$ 36,393	$ 31,145
Cost of sales	11,995	9,106	31,750	27,623
Gross profit	2,093	1,469	4,643	3,522
Selling and administrative expenses	856	809	2,513	2,453
Operating income	1,237	660	2,130	1,069
Other income (expense), net:
Interest expense	(196)	(232)	(586)	(694)
Change in fair value of derivative liabilities		54	9	121
Impairment on investment in iBio, Inc.				(251)
Other income, net	25	9	32	13
Other expense, net	(171)	(169)	(545)	(811)
Income before income taxes	1,066	491	1,585	258
Income tax expense, net	143	103	257	397
Net income (loss)	923	388	1,328	(139)
Change in fair value of derivative liability		(54)
Interest expense on Convertible debt - CD Financial, LLC		55
Accretion of Convertible debt - CD Financial, LLC		9
Diluted net income (loss)	$ 923	$ 398	$ 1,328	$ (139)
Basic net income (loss) per common share (in dollars per share)	$ 0.03	$ 0.02	$ 0.05	$ (0.01)
Diluted net income (loss) per common share (in dollars per share)	$ 0.03	$ 0.01	$ 0.05	$ (0.01)
Weighted average common shares outstanding - basic (in shares)	29,565,943	21,135,174	28,719,452	21,135,174
Add: Equivalent shares outstanding (in shares)	542,782	836,428	582,525
Shares issuable upon conversion of Convertible Debt - CD Financial, LLC (in shares)		8,230,769
Weighted average common shares outstanding - diluted (in shares)	30,108,725	30,202,371	29,301,977	21,135,174